Who Owns Lexicon Pharmaceuticals Stock?
NASDAQ: LXRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 84.35%
- Held by insiders
- 1.13%
- Institutional holders
- 205
- Institutions 84.3%
- Insiders 1.1%
- Public and other 14.5%
Who owns Lexicon Pharmaceuticals stock?
Institutional investors own about 84.3% of Lexicon Pharmaceuticals's shares, spread across 205 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.13% of LXRX.
The largest institutional holders are Artal Group S.A. (39.34%), FMR, LLC (14.99%) and Siren, L.L.C. (9.95%). Together, the top 10 institutions control 77.6% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their LXRX positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LXRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Artal Group S.A. | 175.16M | 39.34% | 0.0% |
| FMR, LLC | 66.74M | 14.99% | +28.9% |
| Siren, L.L.C. | 44.30M | 9.95% | 0.0% |
| Blackrock Inc. | 16.80M | 3.77% | -3.2% |
| Sessa Capital IM, L.P. | 14.36M | 3.23% | -24.3% |
| Vanguard Capital Management LLC | 9.73M | 2.19% | -1.7% |
| State Street Corporation | 7.47M | 1.68% | +51.9% |
| Geode Capital Management, LLC | 5.89M | 1.32% | -5.6% |
| Vanguard Portfolio Management LLC | 2.89M | 0.65% | +22.6% |
| Northern Trust Corporation | 1.94M | 0.44% | -1.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LXRX
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 20.70M | 4.65% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 7.08M | 1.59% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 6.07M | 1.36% |
| iShares Trust-iShares Russell 2000 ETF | 5.91M | 1.33% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 5.71M | 1.28% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 5.07M | 1.14% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 2.72M | 0.61% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.57M | 0.58% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 2.26M | 0.51% |
| iShares Trust-iShares Russell 2000 Growth ETF | 2.13M | 0.48% |
Frequently asked questions
Who is the largest shareholder of Lexicon Pharmaceuticals?
Artal Group S.A. is the largest institutional shareholder of LXRX, owning 39.34% of shares outstanding (175.16M shares) as of its latest 13F filing.
What percentage of Lexicon Pharmaceuticals is owned by institutions?
Institutions own about 84.3% of LXRX shares and 85.3% of the public float.
How much of Lexicon Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 1.13% of LXRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.